Clinical Challenges

Hepatic Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation

Tracy Krimmel

Loretta A. Williams

hematopoietic stem cell transplantation
ONF 2008, 35(1), 37-40. DOI: 10.1188/08.ONF.37-40

Jump to a section

    References

    Anderson-Reitz, L., & Baumert, B.E. (2004). Hepatorenal complications of hematopoietic stem cell transplant. In S. Ezzone (Ed.), Hematopoietic stem cell transplantion (pp. 167-175). Pittsburgh, PA: Oncology Nursing Society.
    Carreras, E., Bertz, H., Arcese, W., Vernant, J.P., Tomas, J.F., Hagglund, H., et al. (1998). Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood, 92(10), 3599-3604.
    Chalandon, Y., Roosnek, E., Mermillod, B., Newton, A., Ozsahin, H., Wacker, P., et al. (2004). Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 10(5), 347-354.
    DeLeve, L., Shulman, H.M., & McDonald, G.B. (2002). Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (venoocclusive disease). Seminars in Liver Disease, 22(1), 27-42.
    Essell, J.H., Schroeder, M.T., Harman, G.S., Halvorson, R., Lew, V., Callander, N., et al. (1998). Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 128(12, Pt. 1), 975-981.
    Goldberg, S.L., Shubert, J., Rao, A.K., Redei, I., Klumpp, T.R., & Mangan, K.F. (1996). Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: Impact on coagulation profile. Bone Marrow Transplantation, 18(3), 633-636.
    Harper, J. (2006). Veno-occlusive hepatic disease. Emedicine. Retrieved June 7, 2007, from http://www.emedicine.com/ped/topic2396.htm
    Helmy, A. (2006). Updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Alimentary Pharmacology and Therapeutics, 23(1), 11-25.
    Ho, V.T., Linden, E., Revta, C., & Richardson, P.G. (2007). Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Review and update on the use of defibrotide. Seminars in Thrombosis and Hemostasis, 33(4), 373-388.
    Jones, R.J., Lee, K.S., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., et al. (1987). Venoocclusive disease of the liver following bone marrow transplantation. Transplantation, 44(6), 778-783.
    Levy, V., Azoulay, D., Rio, B., Vincent, F., Rabbat, A., Hunault, M., et al. (1996). Successful treatment of severe hepatic venoocclusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS). Bone Marrow Transplantation, 18(2), 443-445.
    Lingappa, V. (2003). Liver disease. In V.R. Lingappa, S.J. McPhee, & W.F. Ganong (Eds.), Pathophysiology of disease: An introduction to clinical medicine (4th ed., pp. 380-419). New York: McGraw Hill.
    Mayo Clinic. (2007). Ursodiol. Drugs and Supplements. Retrieved November 15, 2007, from http://www.mayoclinic.com/health/drug-information/dr601407
    O'Connell, S.A. (2000). Complications of hematopoietic cell transplantation. In M.H. Frogge, C.H. Yarbro, M. Goodman, & S.L. Groenwald (Eds.), Cancer nursing: Principles and practice (pp. 523-575). Sudbury, MA: Jones and Bartlett.
    Ohashi, K., Tanabe, J., Watanabe, R., Tanaka, T., Sakamaki, H., Maruta, A., et al. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. American Journal of Hematology, 64(1), 32-38.
    Or, R., Nagler, A., Shpilberg, O., Elad, S., Naparstek, E., Kapelushnik, J., et al. (1996). Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation, 61(7), 1067-1071.
    Ozdogan, O., Ratip, S., Ahdab, Y.A., Dane, F., Ahdab, H.A., Imeryuz, N., et al. (2003). Causes and risk factors for liver injury following bone marrow transplantation. Journal of Clinical Gastroenterology, 36(5), 421-426.
    Park, S.H., Lee, M.H., Lee, H., Kim, H.S., Kim, K., Kim, W.S., et al. (2002). A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 29(2), 137-143.
    Pegram, A.A., & Kennedy, L.D. (2001). Prevention and treatment of veno-occlusive disease. Annals of Pharmacotherapy, 35(7-8), 935-942.
    Rajvanshi, P., Shulman, H.M., Sievers, E.L., & McDonald, G.B. (2002). Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy. Blood, 99(7), 2310-2314.
    Reiss, U., Cowan, M., McMillan, A., & Horn, B. (2002). Hepatic venoocclusive disease in blood and bone marrow transplantion in children and young adults: Incidence, risk factors, and outcomes in a cohort of 241 patients. Journal of Pediatric Hematology and Oncology, 24(9), 746-750.
    Richardson, P.G., Elias, A.D., Krishnan, A., Wheeler, C., Nath, R., Hoppensteadt, D., et al. (1998). Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population. Blood, 92(3), 737-744.
    Ringden, O., Ruutu, T., Remberger, M., Nikoskelainen, J., Volin, L., Vindelov, L., et al. (1994). A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood, 83(9), 2723-2730.
    Rozman, C., Carreras, E., Qian, C., Gale, R.P., Bortin, M.M., Rowlings, P.A., et al. (1996). Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplantation, 17(1), 75-80.
    Vinayek, R., Demetris, J., & Rakela, J. (2000). Liver disease in hematopoietic stem cell transplantation recipients. In E.D. Ball, J. Lister, & P. Law (Eds.), Hematopoietic stem cell therapy (pp. 531-556). New York: Churchill Livingstone.
    Wadleigh, M., Ho, V., Momtaz, P., & Richardson, P. (2003). Hepatic veno-occlusive disease: Pathogenesis, diagnosis, and treatment. Current Opinion in Hematology, 10(6), 451-462.
    Wadleigh, M., Richardson, P.G., Zahrieh, D., Lee, S.J., Cutler, C., Ho, V., et al. (2003). Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood, 102(5), 1578-1582.
    Carreras, E., Bertz, H., Arcese, W., Vernant, J.P., Tomas, J.F., Hagglund, H., et al. (1998). Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood, 92(10), 3599-3604.
    Chalandon, Y., Roosnek, E., Mermillod, B., Newton, A., Ozsahin, H., Wacker, P., et al. (2004). Prevention of veno-occlusive disorder with defibrotide after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 10(5), 347-354.
    Harper, J. (2006). Veno-occlusive hepatic disease. Emedicine. Retrieved June 7, 2007, from http://www.emedicine.com/ped/topic2396.htm
    Jones, R.J., Lee, K.S., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., et al. (1987). Venoocclusive disease of the liver following bone marrow transplantation. Transplantation, 44(6), 778-783.
    O'Connell, S.A. (2000). Complications of hematopoietic cell transplantation. In M.H. Frogge, C.H. Yarbro, M. Goodman, & S.L. Groenwald (Eds.), Cancer nursing: Principles and practice (pp. 523-575). Sudbury, MA: Jones and Bartlett.
    Ozdogan, O., Ratip, S., Ahdab, Y.A., Dane, F., Ahdab, H.A., Imeryuz, N., et al. (2003). Causes and risk factors for liver injury following bone marrow transplantation. Journal of Clinical Gastroenterology, 36(5), 421-426.
    Pegram, A., & Kennedy, L. (2001). Prevention and treatment of veno-occlusive disease. Annals of Pharmacology, 35(7-8), 935-942.
    Reiss, U., Cowan, M., McMillan, A., & Horn, B. (2002). Hepatic venoocclusive disease in blood and bone marrow transplantion in children and young adults: Incidence, risk factors, and outcomes in a cohort of 241 patients. Journal of Pediatric Hematology and Oncology, 24(9), 746-750.
    Wadleigh, M., Ho, V., Momtaz, P., & Richardson, P. (2003). Hepatic veno-occlusive disease: Pathogenesis, diagnosis, and treatment. Current Opinion in Hematology, 10(6), 451-462.